- Report
- February 2025
- 130 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 80 Pages
Middle East
From €5211EUR$5,950USD£4,523GBP
- Report
- September 2025
- 125 Pages
Middle East
From €3722EUR$4,250USD£3,231GBP
- Report
- June 2025
- 100 Pages
United States
From €3065EUR$3,500USD£2,661GBP
- Report
- March 2025
- 200 Pages
United States
From €2181EUR$2,490USD£1,893GBP
- Report
- August 2025
- 121 Pages
United States
From €3502EUR$3,999USD£3,040GBP
- Report
- February 2025
- 146 Pages
Middle East
From €3502EUR$3,999USD£3,040GBP
- Report
- July 2025
- 250 Pages
Middle East, Africa
From €3389EUR$3,869USD£2,941GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3389EUR$3,869USD£2,941GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3389EUR$3,869USD£2,941GBP
- Report
- July 2025
- 250 Pages
North America
From €3389EUR$3,869USD£2,941GBP
- Report
- July 2025
- 250 Pages
Europe
From €3389EUR$3,869USD£2,941GBP
- Report
- July 2025
- 250 Pages
North America
From €3389EUR$3,869USD£2,941GBP
- Report
- February 2025
- 103 Pages
Europe
From €5251EUR$5,995USD£4,557GBP
- Report
- February 2025
- 73 Pages
North America
From €5251EUR$5,995USD£4,557GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4248EUR$4,850USD£3,687GBP
From €4248EUR$4,850USD£3,687GBP
- Report
- June 2025
- 92 Pages
Europe
From €3459EUR$3,950USD£3,003GBP
- Report
- June 2025
- 182 Pages
United States
From €5251EUR$5,995USD£4,557GBP
- Report
- May 2025
- 76 Pages
Middle East, Africa
From €2584EUR$2,950USD£2,242GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more